In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment ...
Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Minimal data are available ...
Two recent deaths tied to for-profit clinics in Canada raised concerns about the health effects of having plasma drawn as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results